CENTOGENE N.V.

(CNTG)
  Bericht
Verzögert Nasdaq  -  27/05 22:00:00
2.800 USD   +3.70%
03.05.Centogene N.V. gibt den Rücktritt von Volkmar Weckesser als Chief Information Officer und Mitglied des Vorstandes bekannt
CI
28.04.Centogene N.V. und Takeda erweitern ihre Partnerschaft für Marktzugang und Expansion, um die Patientenversorgung weltweit zu verbessern
CI
31.03.Centogene N.V. meldet Ergebnis für das Geschäftsjahr zum 31. Dezember 2021
CI
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über CENTOGENE N.V.
25.05.CENTOGENE N : CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platforms..
25.05.CENTOGENE's CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platform..
23.05.CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequ..
23.05.CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequ..
23.05.CENTOGENE N : Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Seq..
19.05.CENTOGENE to Present at the H.C. Wainwright Global Investment Conference
19.05.CENTOGENE to Present at the H.C. Wainwright Global Investment Conference
03.05.Centogene N.V. Announces Resignation of Volkmar Weckesser as Chief Information Officer ..
28.04.CENTOGENE N : and Takeda Extend Market Access and Expansion Partnership to Advance Patient..
28.04.CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient ..
28.04.Centogene N.V. and Takeda Extend Market Access and Expansion Partnership to Advance Pat..
21.04.CENTOGENE N : Minutes of the February 2022 EGM
31.03.Centogene N.V. Reports Earnings Results for the Full Year Ended December 31, 2021
30.03.CENTOGENE N : Reports Fourth Quarter and Fiscal Year 2021 Financial Results - Form 6-K
30.03.TRANSCRIPT : Centogene N.V., Q4 2021 Earnings Call, Mar 30, 2022
30.03.CENTOGENE Reports Fourth Quarter and Full Year 2021 Financial Results
30.03.Centogene N.V. Provides Earnings Guidance for the Year 2022
24.03.CENTOGENE N : MEDIA RELEASE - Form 6-K
24.03.CENTOGENE CEO Kim Stratton to Speak at BIO-Europe Spring® 2022 Conference
23.03.Top Premarket Decliners
23.03.CENTOGENE N : to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 3..
23.03.CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30..
17.03.CENTOGENE N : Announces Expansion of Data Access and Collaboration Agreement With Pfizer -..
17.03.CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer
22.02.CENTOGENE Announces Voting Results of Extraordinary General Meeting
22.02.CENTOGENE N : Announces Voting Results of Extraordinary General Meeting - Form 6-K
22.02.MBMV invests in international bio-tech startup Arcensus GmbH
08.02.Centogene Chief Financial Officer to Resign; Miguel Coego Rios Named as Interim CFO
08.02.CENTOGENE N : Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance..
08.02.CENTOGENE Announces CFO Transition and Appointment of Miguel Coego Rios as EVP Finance ..
08.02.Centogene N.V. Announces Chief Financial Officer Transition
08.02.Centogene N.V. Appoints Miguel Coego Rios as Executive Vice President of Finance & Lega..
03.02.CENTOGENE N : CONVENING NOTICE - Form 6-K
01.02.CENTOGENE N : Announces USD 62 Million Aggregate Equity and Debt Financings to Support Gro..
01.02.Centogene Appoints Kim Stratton as Permanent Chief Executive Officer
01.02.CENTOGENE Announces Nomination of Andreas Busch to Supervisory Board
01.02.CENTOGENE Announces USD 62 Million Aggregate Equity and Debt Financings to Support Grow..
01.02.CENTOGENE Announces Nomination of Kim Stratton as Chief Executive Officer
01.02.Centogene Nominates Kim Stratton as Chief Executive Officer
01.02.Centogene N.V. announced that it has received €14.915363 million in funding from D..
20.01.CENTOGENE N : Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Ta..
20.01.CENTOGENE Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Tar..
20.01.Centogene N.V. and Insilico Medicine Announces Research and Development Collaboration t..
12.01.Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO
04.01.Centogene Rolls Out SaaS Platform for Laboratories
04.01.CENTOGENE N : CentoCloud® Set to Revolutionize Rare Disease Diagnostics With Decentralized..
04.01.CENTOGENE's CentoCloud® Set to Revolutionize Rare Disease Diagnostics With Decentralize..
04.01.Centogene N.V. Announces the Global Release of CentoCloud, A SaaS Platform Enabling Dec..
2021CENTOGENE Wins Award in Digital Healthcare Innovation for Artificial Intelligence (AI) ..
2021OPINIONES DE LOS ANALISTAS DEL DÍA : Tesla, Ryanair, Suse, Knorr-Bremse, BioNTech, Metro A..
2021BOLSA DE MADRID : El mercado quiere su rally bajo el árbol
2021Centogene CEO Andrin Oswald to Take Medical Leave; Interim CEO Named
2021CENTOGENE N : Announces CEO to Take Temporary Medical Leave of Absence – Biopharmace..
2021CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceu..
2021Centogene N.V. Announces Executive Changes
2021Centogene Shares Sink on Wider Q3 Loss, Lower Revenue -- Shares Sink
2021Top Midday Decliners
2021Centogene Q3 Loss Expands as Revenue Slides
2021TRANSCRIPT : Centogene N.V., Q3 2021 Earnings Call, Nov 24, 2021
2021CENTOGENE N : Reports Third Quarter 2021 Financial Results - Form 6-K
2021Centogene N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
2021CENTOGENE Reports Third Quarter 2021 Financial Results
2021Centogene N.V. Provides Earnings Guidance for the Full Year 2021
2021CENTOGENE N : to Announce Third Quarter 2021 Financial Results on November 24, 2021 - Form..
2021CENTOGENE to Announce Third Quarter 2021 Financial Results on November 24, 2021
2021CENTOGENE to Announce Third Quarter 2021 Financial Results on November 24, 2021
2021TRANSCRIPT : Centogene N.V. Presents at 30th Annual Credit Suisse Healthcare Conference, N..
2021CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Dis..
2021CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Dis..
2021CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study - Form ..
2021CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study
2021Centogene N.V. Enrolls First Patient in Frontotemporal Dementia Clinical Study
2021CENTOGENE N : Twist Bioscience Joint Forces to Develop Advanced Sequencing Tools for Rare ..
2021CENTOGENE N : and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Te..
2021CENTOGENE N : and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Te..
1  2  3  4Weiter
Anstehende Termine für CENTOGENE N.V.